Navigation Links
Study finds program has improved health agencies' preparedness for bioterror and disease outbreaks
Date:3/24/2009

A federal program designed to help metropolitan public health agencies prepare to deliver essential medicines to the public after a large-scale bioterror attack or natural disease outbreak has succeeded in improving the level of readiness, according to a new RAND Corporation study.

Researchers found that the federal Cities Readiness Initiative, a program active in 72 metropolitan areas, appears to have improved agencies' ability to rapidly and widely dispense life-saving medications and other medical supplies in the event of a large-scale bioterror attack or a naturally occurring infectious disease outbreak.

The study from RAND Health concludes there is merit in extending the program so the impact can be further monitored, although the analysis did not assess the cost-effectiveness of the effort or compare it to other public health priorities.

"The Cities Readiness Initiative has helped agencies in the nation's most-populous regions become better able to dispense life-saving medication following a bioterrorism event or after an infectious disease outbreak," said Henry Willis, the study's lead author and a policy researcher at RAND, a nonprofit research organization.

Researchers concluded that a key reason the Cities Readiness Initiative has helped promote improvements has been its focus on a single scenario with a well-defined numeric goal and the technical assistance it has provided to public health officials.

Researchers say the initiative has helped increase the number of local public health staff members working on medication dispensing planning, strengthened partnerships between public health officials and local first-responder agencies, and helped pay for new equipment such as mobile drug dispensing units.

Other public health improvements fostered by the Cities Readiness Initiative are the development of more-detailed plans for medication dispensing, including creation of new strategies that rely less on medically trained staff and take greater advantage of nontraditional venues such as hotels, resorts, churches as well as drive-through dispensing in parking lots and fairgrounds.

The Cities Readiness Initiative was created in 2004 to improve the ability of the nation's largest metropolitan regions to provide life-saving medications in the event of a large-scale bioterror attack or naturally occurring disease outbreak. The program has spent about $300 million on efforts thus far.

Administered by the federal Centers for Disease Control and Prevention, the program helps jurisdictions improve their ability to provide antibiotics and other life-saving medications to 100 percent of a region's population within 48 hours of a large-scale anthrax attack or large-scale infectious disease emergency. The 72 regions that have received funding account for about 57 percent of the nation's population.

RAND researchers conducted their study by reviewing plans and technical surveys completed by agencies that assessed capabilities in 12 functional areas (e.g., distribution of medication, dispensing of antibiotics), as well as conducting in-depth interviews with officials from nine regions.

Researchers say that the program should be evaluated again after two to three years to see whether jurisdictions continue to make progress and to examine whether the program should be revised. Future evaluations could be extended to include an assessment of public health risks and the cost-effectiveness of public health programs.


'/>"/>

Contact: Warren Robak
robak@rand.org
310-451-6913
RAND Corporation
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CT (PRWEB) , ... March 28, 2017 , ... ... devices, announces today that the University of Pittsburgh Medical Center (UPMC) will acquire ... and Western Pennsylvania. , The program, developed in association with efforts by the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the ... results and maintaining GMP and USP compliance. In a new webinar from METTLER ... requirements " these requirements are explained. The challenge is to determine how ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the ... care can be limited while the desire to conquer breakouts and eliminate skincare stress ... for every customer online, today released its inaugural survey on the State of Acne ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly ... professionals in the country to sit on the 2017 National Advisory Board for Allergan’s ... years Dr. Harper helped propel the clinic from a small start-up to number 78 ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... MARLBOROUGH, Mass. , March 28, 2017 /PRNewswire/ ... RNAi company developing innovative therapeutics that address significant ... granted a patent from the Japan Patent Office ... targeting connective tissue growth factor (CTGF) for the ... not limited to skin fibrosis and proliferative retinopathy ...
(Date:3/28/2017)... 28, 2017 The global ... 8.0 billion by 2025, according to a new study ... infectious diseases and cancer is expected to upsurge the ... over the coming years. In addition, higher number of ... allogenic stem cell therapy, due to adverse effects caused ...
Breaking Medicine Technology: